Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum; D001254:Astrocytoma / Q000276:immunology*; D001932:Brain Neoplasms / Q000276:immunology*; D002470:Cell Survival; D002478:Cells, Cultured; D003601:Cytotoxicity Tests, Immunologic; D004806:Ependymoma / Q000276:immunology*; D006391:Hemangioma / Q000276:immunology; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007680:Kidney Neoplasms / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D008527:Medulloblastoma / Q000276:immunology*; D008545:Melanoma / Q000276:immunology; D008637:Mesenchymoma / Q000276:immunology; D009447:Neuroblastoma / Q000276:immunology; D012516:Osteosarcoma / Q000276:immunology; D012512:Sarcoma, Ewing / Q000276:immunology; D009396:Wilms Tumor / Q000276:immunology
D000936:Antigen-Antibody Complex; D000961:Antilymphocyte Serum